Cellulose Or Derivative Patents (Class 514/57)
  • Patent number: 10653168
    Abstract: Oral rehydration solutions (ORSs), methods of preparing ORSs and methods of delivering rehydration therapy are disclosed herein. In some embodiments, an ORS includes a non-starch viscosity enhancing polymer and a sodium salt. The ORS may include at least approximately 50 millimoles of dissolved sodium per liter. Other embodiments may be described and/or claimed.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: May 19, 2020
    Assignee: Sweetwater Solutions, LLC
    Inventors: Dwayne Thomas Friesen, Rodney James Ketner, Michael Edward Grass
  • Patent number: 10646574
    Abstract: Provided herein are compositions and methods for preparing intraarticular formulations comprising biocompatible pharmaceutical agents and use thereof in the treatment of diseases, such as degenerative bone diseases, including osteoarthritis of the knee, hip, or other joints, and similar chronic or acute destructive arthropathies resulting from autoimmune disorders or infectious disease.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: May 12, 2020
    Assignee: Board of Regents, The University of Texas System
    Inventors: Jeffrey J. Tarrand, Borje S. Andersson
  • Patent number: 10640632
    Abstract: A method of producing from cellulose pith a composition having bimodal distribution of its components. The composition can be used to modify rheological properties of compositions of matter and for making articles of manufacture and nanocomposites.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: May 5, 2020
    Assignee: BETULIUM OY
    Inventors: Antti Laukkanen, Jason Mckee
  • Patent number: 10624376
    Abstract: A process for preparing an aqueous solution of a methylcellulose having anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups, comprises the step of mixing the methylcellulose with an aqueous liquid at a temperature of not higher than 10° C. at a shear rate of at least 1000 s?1.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: April 21, 2020
    Inventors: Puspendu Deo, Kathryn Brown, David E. Wallick, Robert L. Sammler, Yongfu Li
  • Patent number: 10610095
    Abstract: Generally, a machine may include a processor and a memory connected to the processor, where the memory stores instructions executed by the processor to determine first and second properties related to dry eye symptoms of a patient. The properties may be used to form a dry eye forecast. A treatment recommendation may be selected based at least in part upon the dry eye forecast. The treatment recommendation may be supplied to a device.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: April 7, 2020
    Assignee: Oculeve, Inc.
    Inventors: Manfred Franke, Chao Liu, Abirami Muralidharan, James Donald Loudin, Douglas Michael Ackermann, Michael G. Rogers
  • Patent number: 10549009
    Abstract: The present invention relates to water soluble and completely absorbable and/or physiologically degradable hemostatic compositions having a wax or wax-like base effective for tamponade hemostasis of bone or cartilage.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: February 4, 2020
    Assignee: Abyrx, Inc.
    Inventors: David Knaack, John Pacifico, Marci Wirtz, Richard L. Kronenthal, Frank Do, Aniq Darr
  • Patent number: 10517985
    Abstract: The present invention relates to water soluble and completely absorbable and/or physiologically degradable hemostatic compositions having a wax or wax-like base effective for tamponade hemostasis of bone or cartilage.
    Type: Grant
    Filed: August 7, 2018
    Date of Patent: December 31, 2019
    Assignee: Abyrx, Inc.
    Inventors: David Knaack, John Pacifico, Marci Wirtz, Richard L. Kronenthal, Frank Do, Aniq Darr
  • Patent number: 10350223
    Abstract: The compositions and methods disclosed herein provide for treatments of ocular disorders of the eye, such as ocular surface diseases as well as those associated with inflammation of internal cells and cell layers of the eye. The methods disclosed herein describe methods for treating ocular disorders, particularly dry eye disorders, comprising topically administering to an ocular region of a subject a composition comprising a pharmaceutically effective amount of at least one aldosterone antagonist or salt thereof and a pharmaceutically acceptable carrier. Included is a method for treating dry eye comprising topically administering to an ocular region of a subject a composition comprising spironolactone and hydroxypropyl methylcellulose; and reducing or preventing one or more symptoms or causes of dry eye.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: July 16, 2019
    Inventors: Richard W. Yee, Kenneth Hughes
  • Patent number: 10300085
    Abstract: A nutrient composition, a lipid metabolism-improving agent, and prophylactic and/or therapeutic agents typically for inflammatory bowel diseases, immune disorders, cancers, non-alcoholic steatohepatitis, obesity, diabetes, and hypercholesterolemia each contain a cellulose acetate having a total degree of acetyl substitution of 0.4 to 1.1. The cellulose acetate may be one having a compositional distribution index (CDI) of 2.0 or less, where the CDI is defined by the formula: CDI=(Measured value of half height width of chemical composition)/(Theoretical value of half height width of chemical composition) where the measured value of half height width of chemical composition represents a half height width of chemical composition determined by HPLC analysis of a cellulose acetate propionate prepared by propionylating all residual hydroxy groups of the cellulose acetate (sample), and the theoretical value of half height width of chemical composition =2.
    Type: Grant
    Filed: March 20, 2015
    Date of Patent: May 28, 2019
    Assignee: DAICEL CORPORATION
    Inventors: Shu Shimamoto, Toshikazu Nakamura, Shizuka Ukita, Tsuyoshi Nakamura, Ryoko Yamauchi, Hiroshi Kobayashi, Tatsuya Morita, Tomomi Genda
  • Patent number: 10188675
    Abstract: A nutrient composition contains a cellulose acetate having a total degree of acetyl substitution of 0.4 to 1.1. The cellulose acetate may have a compositional distribution index (CDI) of 2.0 or less, where the CDI is specified by the formula: CDI=(Measured value of half height width of chemical composition)/(Theoretical value of half height width of chemical composition) where the measured value of half height width of chemical composition represents the half height width of chemical composition determined by HPLC analysis of a cellulose acetate propionate prepared by propionylating all residual hydroxy groups of the cellulose acetate (sample); and the theoretical value of half height width of chemical composition=2.35482?{square root over (3*DPw*(DS/3)*(1?DS/3))}/DPw??[Math.
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: January 29, 2019
    Assignee: DAICEL CORPORATION
    Inventors: Shu Shimamoto, Toshikazu Nakamura, Shizuka Ukita, Tsuyoshi Nakamura, Ryoko Yamauchi, Hiroshi Kobayashi
  • Patent number: 10034957
    Abstract: The present invention is directed to a hemostatic material comprising a compacted, hemostatic aggregates of cellulosic fibers. In some aspects, the hemostatic material further includes additives, such as carboxymethyl cellulose (CMC) or other polysaccharides, calcium salts, anti-infective agents, hemostasis promoting agents, gelatin, collagen, or combinations thereof. In another aspect, the present invention is directed to a method of making the hemostatic materials described above by compacting a cellulosic-based material into hemostatic aggregates. In another aspect, the present invention is directed to a method of treating a wound by applying hemostatic materials described above onto and/or into the wound of a patient.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: July 31, 2018
    Assignee: Ethicon LLC
    Inventor: Yi-Lan Wang
  • Patent number: 9956167
    Abstract: Described is an intra-mammary teat sealant and a corresponding method of forming a physical barrier in the teat canal of a non-human animal for prophylactic treatment of mammary disorders during the animal's dry period. The method includes the step of infusing a teat seal formulation including a metal salt in a glyceride-containing gel base into the teat canal of the animal. The method also prevents the formation of black spot defect in dairy products, especially cheddar cheese, made from the milk of animals so treated.
    Type: Grant
    Filed: April 7, 2010
    Date of Patent: May 1, 2018
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventor: Scott A. Rankin
  • Patent number: 9932461
    Abstract: A microfibrous cellulose aggregate including microfibrous cellulose having an average fiber width of 2 nm to 50 nm and a liquid compound including at least one of water or an organic solvent. The content of the microfibrous cellulose is from 6 mass % to 80 mass % per the mass of the entire microfibrous cellulose aggregate, and the content of the liquid compound is at least 15 mass % per the mass of the entire microfibrous cellulose aggregate.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: April 3, 2018
    Assignee: Oji Holdings Corporation
    Inventors: Go Banzashi, Hiroyuki Nagatani, Shino Iwai
  • Patent number: 9861722
    Abstract: Disclosed is a method for preparing an oxidized cellulose hemostatic product, including using a sodium hydroxide solution with the concentration of 1 to 5% to pre-process a cellulose product; after removing lignins or impurities on the fiber surface, using an alkaline solution to activate the fiber surface further; after the activating treatment, using demin-water for washing until it is neutral and drying the obtained cellulose product in air to obtain a raw material; using a sodium hydroxide solution with the concentration of 5 to 20% as a solvent; adding the cellulose product, carbamide and ZnO that are 3 to 10%, 2% and 2% of the sodium hydroxide solution respectively.
    Type: Grant
    Filed: July 4, 2016
    Date of Patent: January 9, 2018
    Assignees: Hangzhou Singclean Medical Products Co., Ltd, Zhejiang University of Science and Technology
    Inventors: Zhiguo Zhang, Yange Suo, Wei Huang, Weiqing Sun
  • Patent number: 9833006
    Abstract: Methods are provided for making a fermented milk product in which a stabilizing additive is introduced before fermentation. The methods generally include (1) combining milk and pectin to form a mixture, (2) heat treating the mixture, and (3) fermenting the mixture. In some embodiments, the methods further include combining the milk and pectin with a low acyl gellan gum. The methods also may include homogenizing the mixture before heat treating the mixture and/or after fermenting the mixture. Also provided in embodiments herein are fermented milk products.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: December 5, 2017
    Assignee: CP Kelco APS
    Inventors: Lian Ying Ng, Soeren Bulow Riis, Tina Benne Lohmann, Min Ling Marlene Tsao, Camilla Bjergegaard
  • Patent number: 9832993
    Abstract: A method for forming a composition that includes mixing an antimicrobially active botanical oil (e.g., thymol, carvacrol, etc.) and a modified starch polymer within a melt blending device (e.g., extruder) is provided. Unlike the problems associated with proteins, the use of starch polymers allows for a greater degree of flexibility in the processing conditions and is still able to achieve good properties in the resulting composition. The present inventors have also discovered that a plasticizer may be employed to facilitate melt processing of the starch, as well as to enhance the ability of the botanical oil to flow into the internal structure of the starch where it can be retained in a stable manner. The composition is also typically generally free of solvents. In this manner, the starch will not generally disperse before use and prematurely release the botanical oil.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: December 5, 2017
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: James H. Wang, Bo Shi, JaeHong Lee, Vasily A. Topolkaraev, Neil T. Scholl, YoungSook Kim
  • Patent number: 9642929
    Abstract: The present invention relates to a highly liquid absorbent and hardly water-soluble carboxymethyl cellulose (CMC) foam, which absorbs body fluid or water, expands in volume when absorbing liquid, does not gelate, and maintains shape. The hardly water-soluble CMC foam prepared according to the preparation method of the present invention has remarkably superior liquid absorption property, shows large volume expansibility when absorbing liquid, does not gelate, and maintains shape. Therefore, a remarkably improved ability is shown when used as a hemostatic agent and a wound dressing. In addition, when the CMC foam is treated with a CMC powder dispersing liquid, the surface characteristics change, thereby preventing adhesion with the skin and improving liquid retention capability. Thus, it is possible to control the liquid absorption property thereof to meet the desired purpose.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: May 9, 2017
    Assignee: Korea Institute of Industrial Technology
    Inventors: Jung Nam Im, Song Jun Doh, Tae Hee Kim, Min Ji Yoon, Chae Hwa Kim
  • Patent number: 9603824
    Abstract: The invention features methods of inhibiting the growth of, or killing, fungal and certain bacterial microorganisms with one or more of a family of glycerol-based compounds.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: March 28, 2017
    Assignee: Regents of the University of Minnesota
    Inventors: Patrick M. Schlievert, Marnie L. Peterson
  • Patent number: 9579401
    Abstract: The invention is directed to a staining composition and to the use of the staining composition in staining ocular tissue. In a first aspect, the invention provides a staining composition comprising a vital dye and a density increasing compound chosen from the group consisting of water soluble polymers and small inert molecules.
    Type: Grant
    Filed: April 1, 2011
    Date of Patent: February 28, 2017
    Assignee: Medical Technology Transfer Holding B.V.
    Inventor: Gerrit Reinold Jacob Melles
  • Patent number: 9439971
    Abstract: The use of water-soluble or water-dispersible copolymers which are obtained by free radical-initiated polymerization of a mixture of i) 30 to 80% by weight N-vinyllactam, ii) 10 to 50% by weight vinylacetate and iii) 10 to 50% by weight of a polyether, with the proviso that the total of i), ii) and iii) is equal to 100% by weight, as binders for producing solid active ingredient-containing dosage forms.
    Type: Grant
    Filed: January 2, 2013
    Date of Patent: September 13, 2016
    Assignee: BASF SE
    Inventors: Kathrin Meyer-Böhm, Rainer Dobrawa, Angelika Maschke, Karl Kolter
  • Patent number: 9345809
    Abstract: Compositions comprising carboxypolysaccharides (CPS) including carboxymethyl cellulose (CMC) and polyethylene glycols (PEGs) are provided where the PEG is a PEG-epoxide covalently linked to the CPS via an addition reaction. In certain embodiments, the PEG attaches to only one CPS, forming a decorated CPS. In other embodiments, bi-functional PEG molecules are attached to adjacent CPSs, thereby forming a covalently cross-linked composition. In certain of these embodiments, a PEG is linked to the CPS by way of an ether linkage, and in other embodiments, a PEG is linked to the CPS by way of an ester linkage, and in still further embodiments, PEG molecule(s) can be attached to CPS molecule(s) by way of both ether and ester linkages. Additional embodiments include PEG/CMC compositions where the PEG is a multi-branch PEG and/or a multi-arm PEG.
    Type: Grant
    Filed: November 28, 2007
    Date of Patent: May 24, 2016
    Assignee: FZIOMED, Inc.
    Inventors: Samuel J. Falcone, Richard A. Berg
  • Patent number: 9339450
    Abstract: The invention relates to a composition that can be subcutaneously or intradermally injected, comprising: a filling agent; and a fibroblast growth medium.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: May 17, 2016
    Inventors: Jean-Noel Thorel, Hugues Gatto
  • Patent number: 9149045
    Abstract: An oil-in-water emulsion that is environmentally friendly and also exhibits antimicrobial activity is provided. More specifically, the oil phase of the emulsion includes a botanical oil derived from a plant (e.g., thymol, carvacrol, etc.). Because the botanical oil tends to leach out of the emulsion during storage and before it is used in the desired application, a water-dispersible polymer is also employed in the aqueous phase of the emulsion to enhance long term stability of the oil and, in turn, antimicrobial efficacy. Without intending to be limited by theory, it is believed that the water-dispersible polymer can effectively encapsulate the botanical oil within the emulsion and inhibit its premature release. Once the emulsion is formed, water can then be removed so that it becomes a substantially anhydrous concentrate. In this manner, the water-dispersible polymer will not generally disperse before use and prematurely release the botanical oil.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: October 6, 2015
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: JaeHong Lee, Vasily A. Topolkaraev, David W. Koenig, Neil T. Scholl, YoungSook Kim, James H. Wang
  • Patent number: 9085525
    Abstract: Chiral salts comprising anionic cyclodextrin derivatives with particular types of non-metal cations are provided. The anionic CD derivative salts can serve as ionic liquids and can possess substantial advantages over currently commercially available ionic liquids particularly for use as chiral phase transfer catalyst, chiral reaction medium, chiral extraction medium, and/or as chiral additive to a chemical process. Methods of preparing the same are provided.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: July 21, 2015
    Inventor: Jose R Matos
  • Publication number: 20150147311
    Abstract: A process for mechanical destructuring of cellulosic biomass was developed that makes use of a short application of high compression, impact, and shearing forces. The biomass may be destructured using a specific energy input that is less than 40% of the total combustible energy of the biomass. The destructured biomass, with or without saccharification and/or in-feed glycosyl hydrolase enzymes, may be used in feed applications.
    Type: Application
    Filed: November 18, 2014
    Publication date: May 28, 2015
    Inventors: Wathudura Indika Namal De Silva, Paul Joseph Fagan, F. Glenn Gallagher, Zheng-Zheng Huang, Guangliang Gary Liu, Aaron Perelman, Luis Fernando Romero Millan, Anton Shpilsky, Daniel A. Slanac, Maria Walsh
  • Publication number: 20150141371
    Abstract: A composition for use in a human by oral administration to reduce or control cardiometabolic risk factors associated with metabolic syndrome or hypercholesterolemia, or reduce risk of developing metabolic syndrome or hypercholesterolemia. The composition includes a combination of Arabinogalactan and Dihydroquercetin (taxifolin), where the Arabinogalactan is present in the combination as a fiber matrix in an amount higher than 70% as determined by weight on dry matter basis, and the Dihydroquercetin is present in the fiber matrix.
    Type: Application
    Filed: January 26, 2015
    Publication date: May 21, 2015
    Inventors: Sergey V. Philippov, Igor M. Bogorodov
  • Publication number: 20150135644
    Abstract: A wound dressing comprising acylated chitosan fibre. The dressing has a wet strength of 0.3 N/cm or above. The acylated chitosan fibre may have a degree of substitution of 0.10-0.50. The acylated chitosan fibre may preferably have a degree of substitution of 0.20-0.40. The dressing may have an absorbency of 5-25 g/g of a solution containing 8.298 g/l of sodium chloride and 0.368 g/l of calcium chloride dehydrate as measured by BSEN 13726-12002 Part 1 Aspects of Absorbency. The base material of the dressing may be chitosan fibre that has been chemically modified through an acylation process using anhydride and ethanol as the solvent. A method of manufacturing the wound dressing involves reacting chitosan fibre with anhydride and making acylated chitosan felt through a nonwoven process, and through cutting, packing and sterilizing processes.
    Type: Application
    Filed: January 17, 2012
    Publication date: May 21, 2015
    Inventors: Xiaohui Mo, Xiaodong Wang, Zhenjun Wu
  • Patent number: 9034843
    Abstract: The present invention provides an ophthalmic composition which stabilizes the tear film during wearing contact lens, prevents eye dryness, imparts a favorable sensation in using, is highly convenient with no risk of misuse and shows a high efficiency in the course from manufacturing to sales. More specifically, the present invention provides a wetting solution—eye drops for contact lenses comprising (A) one or more member(s) selected from the group consisting of a cellulose-based polymer, a vinyl-based polymer, polyethylene glycol and dextran; and (B) one or more member(s) selected from the group consisting of chondroitin sulfate, alginic acid and salts thereof; and (C) a nonionic surfactant.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: May 19, 2015
    Assignee: Rohto Pharmaceutical Co., Ltd.
    Inventors: Yasuko Matsumura, Kazuhiro Fukushima
  • Patent number: 9023830
    Abstract: There is disclosed a cosmetic comprises a sugar compound obtained by reacting a hydroxyl group of a saccharide, an isocyanate group-containing organopolysiloxane represented by the following general formula (1), and an isocyanate group-containing organic compound represented by the following general formula (2). As a result, there is provided a cosmetic excellent in cosmetic sustainability and storage stability that can improve such undesirable feelings of use as insufficient spreadability and stickiness, improve the solubility to not only a non-polar oil such as a silicone oil and a light liquid paraffin, but also a polar oil such as a UV-absorber, an ester oil, and a natural animal and vegetable oil, provides non-stickiness with a cosmetic containing the polar oil, and prevent adhesion of the cosmetic to clothes (secondary adhesion).
    Type: Grant
    Filed: March 21, 2013
    Date of Patent: May 5, 2015
    Assignee: Shin-Etsu Chemical Co., Ltd.
    Inventor: Masanao Kamei
  • Patent number: 9023333
    Abstract: The invention relates to the use of a shaped article containing at least one skeleton-forming agent, proteins being excepted, optionally one or more active substances and also optionally one or more auxiliary substances for the purpose of external application, to a process for producing the stated shaped articles, and also to novel shaped articles.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: May 5, 2015
    Inventors: Stefan Frahling, Ralf Malessa
  • Patent number: 9018189
    Abstract: The invention relates to use of microfibrillated cellulose as an anti-inflammatory agent for treatment of skin disorders.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: April 28, 2015
    Assignee: UPM-Kymmene Oyj Corporation
    Inventors: Kaisa Herranen, Mia Lohman
  • Publication number: 20150093424
    Abstract: Formulations having, as active agents, at least one quaternized polymeric microgel and at least one surfactant, methods of making, and methods of using are described.
    Type: Application
    Filed: December 11, 2014
    Publication date: April 2, 2015
    Applicant: The University of Toledo
    Inventors: Yakov Lapitsky, Youngwoo Seo
  • Patent number: 8993539
    Abstract: The present invention provides a composition of dietary fiber supplements for satiety enhancement and appetite suppression in treatment of overweight, obesity, or eating disorders. The composition of the dietary fiber supplements consist of at least one cationic polymer and at least one anionic polymer. The cationic polymers and the anionic polymers in the composition can be dissolved or dispersed in an aqueous solution. When the pH of the aqueous solution is lowered, such as the solution is ingested into the stomach with a gastric pH environment or the aqueous solution is added with some acidifying agents, the aqueous solution will turn into a gel. The formation of a gel from the aqueous solution after it being ingested into the stomach before a meal would provide a satiety enhancement and appetite suppression effect.
    Type: Grant
    Filed: September 22, 2013
    Date of Patent: March 31, 2015
    Inventor: Guang Yan
  • Patent number: 8992890
    Abstract: The invention discloses pharmaceutical compositions in the form of a dusting powder or dry spray, possessing a high absorbent capacity, painkilling activity and wound-healing action, which compositions consist of croscarmellose sodium, a non-steroidal anti-inflammatory drug (NSAID) and hyaluronic acid, and optionally also contain other pharmacologically active substances and/or excipients. The compositions disclosed herein are suitable for use in the treatment of skin lesions wherein the presence of exudate limits wound healing and causes pain; they are therefore particularly suitable for chronic ulcerous skin lesions of various origins and burns.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: March 31, 2015
    Assignee: Fidia Farmaceutici S.p.A.
    Inventors: Andrea Pastorello, Devis Galesso, Fabio Bettella
  • Patent number: 8993537
    Abstract: Scaffold comprises a polymer defining macropores and comprising hydroxypropylcellulose partially substituted by a substituent comprising a self-crosslinkable group, which is crosslinked through the self-crosslinkable group. The macropores have an average pore size larger than 50 microns and are at least partially interconnected. In one method, bicontinuous emulsion comprising a continuous aqueous phase and a continuous polymer phase is formed. The polymer phase comprises hydroxypropylcellulose partially substituted by a substituent comprising a self-crosslinkable group, and is crosslinked through the self-crosslinkable group to form a polymer defining at least partially interconnected pores. In another method, phase separation is induced in a solution comprising a polymer precursor and water to form a bicontinuous emulsion comprising a continuous polymer phase and a continuous aqueous phase.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: March 31, 2015
    Assignee: Agency for Science, Technology and Research
    Inventors: Zhilian Yue, Feng Wen, Hanry Yu
  • Patent number: 8993299
    Abstract: The present invention relates to polypeptides having cellobiohydrolase I activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: March 31, 2015
    Assignee: Novozymes A/S
    Inventors: Lene Lange, Wenping Wu, Dominique Aubert, Sara Landvik, Kirk Matthew Schnorr, Ib Groth Clausen
  • Patent number: 8986667
    Abstract: The present invention relates to a mixture, having a skin-tightening effect, which is made up of: 10 to 80% by weight of a polysaccharide, preferably of an alginate, having a molecular weight of less than 600,000 Daltons, preferably less than 400,000 Daltons and more preferably less than 200,000 Daltons, 15 to 75% by weight of a polyhydroxylated agent selected from sugars and their derivatives, particularly sugar esters and sugar, ethers, preferably sorbitol, 3 to 15% by weight of poly(vinyl alcohol) or polyvinylpyrrolidone, and 0 to 25% by weight of cellulose or of a derivative of cellulose, such as carboxymethylcellulose or hydroxymethylcellulose. The present invention also relates to cosmetic compositions which contain this mixture. These cosmetic compositions enable a mechanical smoothing of the surface of the skin to be obtained progressively with great comfort of use and enables a good fixing of make-up products.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: March 24, 2015
    Assignee: LVMH Recherche
    Inventors: Hervé Delage-Grouiller, Brigitte Noe, Christian Mahe
  • Patent number: 8986969
    Abstract: The present invention relates to polypeptides having cellobiohydrolase I activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: October 28, 2013
    Date of Patent: March 24, 2015
    Assignee: Novozymes A/S
    Inventors: Lene Lange, Wenping Wu, Dominique Aubert, Sara Landvik, Kirk Matthew Schnorr, Ib Groth Clausen
  • Publication number: 20150080297
    Abstract: The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.
    Type: Application
    Filed: June 23, 2014
    Publication date: March 19, 2015
    Inventors: Anna Christina GOEDHART, Martine Sandra Alles, Katrien Maria Jozefa Van Laere
  • Publication number: 20150080336
    Abstract: The present invention relates to an association of beta-glucans from a first cereal and arabinoxylans from a second cereal different from the first cereal, and their use to improve the microbiota balance in human gut.
    Type: Application
    Filed: April 23, 2013
    Publication date: March 19, 2015
    Inventors: Isabel Moreira De Almeida, Alexandra Meynier, Maria Urbieta
  • Publication number: 20150072946
    Abstract: A process for the preparation of nanoparticles from polysaccharides and derivatives thereof, by their specific partial oxidation to produce aldehyde groups and attachment of compounds with amino or other group with the R—NH2 bond which react with aldehyde groups, and a nanoparticle produced by such process.
    Type: Application
    Filed: September 12, 2014
    Publication date: March 12, 2015
    Inventors: Tomasz CIACH, Iga WASIAK
  • Patent number: 8969321
    Abstract: The present invention provides a method for using processed cellulose. Preferably, the processed cellulose is a highly refined cellulose (HRC). The HRC is useful in a number of medical and nutritional applications. These medical and nutritional applications can include, but are not limited to, administering effective amounts of the HRC for lowering values of risk factor measurements for such diseases as arteriosclerotic cardiovascular disease and diabetes. Treatment of other diseases and conditions with the HRC is also possible.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: March 3, 2015
    Assignee: Regents of the University of Minnesota
    Inventors: Paul Bradley Addis, Rongsheng Roger Ruan, Joseph M. Keenan, Daniela Geleva
  • Publication number: 20150057244
    Abstract: This invention provides a method of preventing or treating a dermatologic condition including, inter alia, psoriasis, contact dermatitis, and atopic dermatitis, in a subject, the method includes the step of administering to said subject a compound comprising a lipid or phospholipid moiety bound to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof, in an amount effective to treat the subject suffering from a dermatologic condition.
    Type: Application
    Filed: November 5, 2014
    Publication date: February 26, 2015
    Inventors: SAUL YEDGAR, Miron Krimsky, Arie Ingber
  • Patent number: 8962594
    Abstract: The method of using nutritional compounds including Dihydroquercetin (taxifolin). Arabinogalactan and Arabinogalactan combined with Dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors, associated with metabolic syndrome and hypercholesterolemia in a mammal, specifically a human, resulting in the enhancement of metabolism, reduced control levels of cholesterol and triglycerides, reduced oxidative damage in humans and other health benefits.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: February 24, 2015
    Assignee: Flavitpure, Inc.
    Inventors: Sergey V. Philippov, Igor M. Bogorodov
  • Publication number: 20150051169
    Abstract: There is a need for water-based sperm- and egg-friendly vaginal lubricant. We describe novel water-based nature-friendly personal moisturizers and lubricants that relive vaginal dryness. In addition to being non-spermicidal, sperm- and egg-friendly and biological-fluids mimicking, these personal moisturizers and lubricants also enhance sperm survival and motility, promote binding of sperm to eggs and facilitate the process of fertilization. Novel articles, and systems as well as methods of preparation and use of the novel compositions are also provided.
    Type: Application
    Filed: October 29, 2014
    Publication date: February 19, 2015
    Applicant: AQUATROVE BIOSCIENCES, INC.
    Inventors: Vibha Gupta, Vineet Gupta, Boris Nikolic
  • Patent number: 8957048
    Abstract: The present invention relates to ophthalmic compositions and methods useful to treat dry eye, or to diagnose, cure, mitigate, treat, or prevent dry eye syndrome in man or other animals.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: February 17, 2015
    Assignee: Allergan, Inc.
    Inventors: Joseph G. Vehige, Peter A. Simmons
  • Publication number: 20150045320
    Abstract: A flowable or spoonable medicament, food, food ingredient or food supplement is useful for inducing satiety. It comprises (a) one or more mono-, di- and/or oligosaccharides and (b) a methylcellulose, wherein the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is from 0.17 to 0.36, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups.
    Type: Application
    Filed: October 11, 2012
    Publication date: February 12, 2015
    Applicant: DOW GLOBAL TECHNOLOGIES LLC
    Inventors: Roland Adden, Matthias Knarr, Britta Huebner-Keese, Robert L. Sammler
  • Patent number: 8951989
    Abstract: A hydrogel tissue adhesive having decreased degradation time is described. The hydrogel tissue adhesive is formed by reacting an oxidized polysaccharide with a water-dispersible, multi-arm polyether amine in the presence of an oligomer additive, which promotes the degradation of the hydrogel. The hydrogel may be useful as a tissue adhesive or sealant for medical applications, such as a hemostat sealant or to prevent undesired tissue-to-tissue adhesions resulting from trauma or surgery.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: February 10, 2015
    Assignee: Actamax Surgical Materials, LLC
    Inventor: Mark E. Wagman
  • Publication number: 20150037383
    Abstract: The compositions and methods of this invention relate to a leave-on skin care composition containing hydrophobic, linear cellulose particles having an average length of from about 1 to about 500 ?m, a particle aspect ratio from about 2 to about 25 and an average thickness of from about 1 to about 500 ?m; and a cosmetically acceptable carrier.
    Type: Application
    Filed: October 23, 2014
    Publication date: February 5, 2015
    Inventors: Patricia Bonner, Claudia Kaminski, Danielle Lima Lorenzetti, Prithwiraj Maitra, Juliana Salles Moscardi, Jeffrey M. Wu
  • Patent number: 8932622
    Abstract: Disclosed herein are a kit and a method for forming a tissue coating that prevents undesired tissue-to-tissue adhesions resulting from trauma, surgery, infection, or other stimulus. The tissue coating is a hydrogel formed by reacting an aminocarboxymethyldextran containing primary amine groups with an oxidized carboxymethylcellulose containing aldehyde groups.
    Type: Grant
    Filed: June 1, 2009
    Date of Patent: January 13, 2015
    Assignee: Actamax Surgical Materials, LLC
    Inventor: Steven W. Shuey